Ngee-Soon Lau

Ngee-Soon Lau

Auto-generated profile, based on publicly available information

Ngee-Soon Lau

Australian National Liver Transplantation Unit Royal Prince Alfred Hospital Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NLNgee-Soon Lau
Ngee-Soon Lau
MLMark Ly
Mark Ly
CDClaude Dennis
Claude Dennis
AJAndrew Jacques
Andrew Jacques
MCMarti Cabanes-Creus
Marti Cabanes-Creus
Carlo PulitanoCarlo Pulitano
Carlo Pulitano
Current machine perfusion technology permits livers to be preserved ex situ for short periods to assess viability prior to transplant. Long-term normothermic perfusion of livers is an emerging field with tremendous potential for the assessment, recovery, and modification of organs. In this study, we aimed to develop a long-term model of ex situ perfusion including a surgical split and simultaneous perfusion of both partial organs. Human livers declined for transplantation were perfused using a red blood cell-based perfusate under normothermic conditions (36 °C) and then split and simultaneously perfused on separate machines. Ten human livers were split, resulting in 20 partial livers. The median ex situ viability was 125 h, and the median ex situ survival was 165 h. Long-term survival was demonstrated by lactate clearance, bile production, Factor-V production, and storage of adenosine triphosphate. Here, we report the long-term ex situ perfusion of human livers and demonstrate the ability to split and perfuse these organs using a standardised protocol.

5 August 2022 in Artificial Organs
Verified
Journal Article
Open access
NLNgee‐Soon Lau
Ngee‐Soon Lau
MLMark Ly
Mark Ly
CDClaude Dennis
Claude Dennis
KLKen Liu
Ken Liu
JKJames Kench
James Kench
Carlo PulitanoCarlo Pulitano
Carlo Pulitano
In this case report, we preserved human livers for up to 13 days under normothermic conditions using a modified commercial perfusion system. Two whole livers were split into two left lateral segment grafts and two extended right grafts without interruption to blood flow and then perfused on separate machines. Not only does this provide the basis for a meaningful study of liver function in the long term, but this could also facilitate the development of a model of ex situ liver regeneration.

8 February 2023 in HPB
Verified
Journal Article
Closed access
NLNgee-Soon Lau
Ngee-Soon Lau
MLMark Ly
Mark Ly
CDClaude Dennis
Claude Dennis
KEKasper Ewenson
Kasper Ewenson
HLHayden Ly
Hayden Ly
Carlo PulitanoCarlo Pulitano
Carlo Pulitano

21 January 2019 in BMC Surgery
Verified
Journal Article
Open access
PDF file
NLNgee-Soon Lau
Ngee-Soon Lau
NANima Ahmadi
Nima Ahmadi
Deborah VerranDeborah Verran
Deborah Verran
Abdominal wall surgical site complications following renal transplantation can be challenging to manage. A sub-group of these recipients will require operative management or advanced wound care such as negative pressure wound therapy (NPWT). The aim of this study was to determine if there were any preoperative, intraoperative and postoperative characteristics in our recipients’ cohort which were associated with the requirement for such interventions. A retrospective review of medical records was performed for all recipients who sustained abdominal wall complications following renal transplantation at our centre from 2006 to 2016. A total of 64/828 recipients (7.7%) had abdominal wall complications. The mean weight for these patients was 84.9 kg (±16.6 kg) and the mean body mass index was 30.2 (±5.1). Forty-five recipients (70%) had a superficial wound dehiscence while nine (14%) had a complete fascial dehiscence. Operative intervention was required in 13/64 patients (20%) and was more likely to be required in the presence of a fascial dehiscence (9/9, 100%) or a wound collection (10/31, 32%) (p < 0.001, p = 0.021). NPWT was used in 17/64 patients (27%) and was more commonly required in patients with diabetes mellitus (10/24, 42%), a complete fascial dehiscence (5/9, 56%) or evidence of infection (16/44, 36%) (p = 0.039, p = 0.034, p = 0.008). The requirement for either operative management or the use of NPWT in the management of abdominal wall complications following renal transplantation in our experience was more common in recipients with diabetes mellitus, and in the setting of either complete fascial dehiscence, abdominal wall wound collections and/ or infection.

24 July 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
MLMark Ly
Mark Ly
NLNgee-Soon Lau
Ngee-Soon Lau
CDClaude Dennis
Claude Dennis
JCJinbiao Chen
Jinbiao Chen
CRCharles Risbey
Charles Risbey
Carlo PulitanoCarlo Pulitano
Carlo Pulitano
Bile duct regeneration is hypothesised to prevent biliary strictures, a leading cause of morbidity after liver transplantation. Assessing the capacity for biliary regeneration may identify grafts as suitable for transplantation that are currently declined, but has been unfeasible until now. This study used Long-Term Ex-Situ Normothermic Machine Perfusion (LT-NMP) to assess biliary regeneration. Human livers that were declined for transplantation were perfused at 36°C for up to 13.5 days. Bile duct biopsies, bile and perfusate were collected throughout perfusion, which were examined for features of injury and regeneration. Biliary regeneration was defined as new Ki-67 positive biliary epithelium following severe injury. Ten livers were perfused for a median duration of 7.5 days. Severe bile duct injury occurred in all grafts, and biliary regeneration occurred in 70% of grafts. Traditional biomarkers of biliary viability such as bile glucose improved during perfusion but this was not associated with biliary regeneration (p>0.05). In contrast, the maintenance of IL-6 and VEGF-A levels in bile were associated with biliary regeneration (p=0.017 for both cytokines). This is the first study to demonstrate biliary regeneration during LT-NMP and identify a cytokine signature in bile as a novel biomarker for biliary regeneration during LT-NMP.

26 April 2022 in Clinical Transplantation
Verified
Journal Article
Open access
NLNgee‐Soon Lau
Ngee‐Soon Lau
MLMark Ly
Mark Ly
KLKen Liu
Ken Liu
AMAvik Majumdar
Avik Majumdar
SSSimone I. Strasser
Simone I. Strasser
Carlo PulitanoCarlo Pulitano
Carlo Pulitano
Introduction: Split liver transplantation (SLT) enables two recipients to be transplanted using a single donor liver; typically, an adult and a child. Despite equivalent long‐term outcomes to whole grafts in selected adults, the use of these grafts in high‐risk adult recipients with high model for end‐stage liver disease (MELD) scores (≥30), a poor pre‐transplant clinical status (ICU or hospital‐bound), acute liver failure or retransplantation remains controversial.Methods: We retrospectively analyzed all deceased donor adult liver transplants performed between July 2002 and November 2019 at a single high‐volume center and performed a propensity score‐matched analysis. A subgroup analysis was performed to assess utility of these grafts for high‐risk recipients.Results: A total of 1090 adult liver transplants were performed, including 155 SLT (14%). Graft survival at 1‐, 3‐ and 5‐years were comparable between recipients of split and whole liver grafts (82%, 79% and 74% vs. 86%, 81% and 77%, respectively, log rank P = .537), as was patient survival at 1‐, 3‐ and 5‐years. Recipients of split grafts were more likely to have biliary complications and hepatic artery thrombosis, but equivalent long‐term survival. Recipients with high MELD scores or a poor pre‐transplant clinical status had similar patient and graft survival and complication profiles irrespective of whether they received split or whole grafts.Conclusions: SLT is an important method for addressing donor shortages and provides comparable long‐term outcomes in adult recipients despite an increase in short‐term complications. SLT use in high‐risk recipients should be considered to allow for sickest‐first allocation policies.